Skip to main content

AI-Based Radiomic Model Improves Diagnosis of Crohn Disease

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

THURSDAY, Aug. 10, 2023 -- In a study published Aug. 2 in the American Journal of Roentgenology, a radiomic machine learning model predicted Crohn's disease diagnosis with better performance than two of three expert radiologists.

Richard X. Liu, Ph.D., from the University of Cincinnati College of Medicine, and colleagues developed a machine learning-based method for predicting ileal Crohn's disease using radiomic features of ileal wall and mesenteric fat from noncontrast T2-weighted magnetic resonance (MR) images. Performance of the artificial intelligence (AI) model was compared to the performance of expert radiologists.

The researchers found that for 135 patients, the three radiologists had accuracies of 83.7, 86.7, and 88.1 percent for diagnosing Crohn's disease, with consensus accuracy of 88.1 percent. There was substantial inter-radiologist agreement (κ = 0.78). The bowel core was the best-performing region of interest (area under the receiver operating characteristic curve [AUC], 0.95; accuracy, 89.6 percent); whole bowel fat core and whole fat had worse performance (whole bowel AUC, 0.86; fat core AUC, 0.70; whole-fat AUC, 0.73). A clinical-only model achieved an AUC of 0.85 and accuracy of 80.0 percent, while an ensemble model combining bowel-core radiomic and clinical models achieved AUC of 0.98 and accuracy of 93.5 percent. The bowel-core radiomic-only model had better accuracy than radiologist 1 and radiologist 2, but not radiologist 3 or radiologists' consensus. The ensemble model achieved better accuracy than radiologists' consensus.

"Deployment of a radiomic-based model using T2-weighted MR data could decrease inter-radiologist variability and increase diagnostic accuracy for pediatric Crohn's disease," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

Risk for Most Cardiovascular Diseases No Higher With Inflammatory Bowel Disease

FRIDAY, May 3, 2024 -- Among postmenopausal women with inflammatory bowel disease (IBD), there is no higher risk for cardiovascular disease (CVD) compared with women without IBD...

Study IDs Risk Factors for Extraintestinal Manifestations of IBD

WEDNESDAY, April 17, 2024 -- Certain demographic, clinical, and genetic factors heighten the risk for extraintestinal manifestations (EIMs) with inflammatory bowel disease (IBD)...

Higher Vitamin D Levels Cut Bowel Resection Risk With IBD

WEDNESDAY, April 3, 2024 (HealthDay News) -- An increased serum level of 25-hydroxyvitamin D (25[OH]D) is independently associated with a lower risk for bowel resection with...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.